Lung cancer is far and away the leading cause of cancer deaths worldwide. In the U.S. alone, a projected 142,000 people will die of the disease this year.

A new five-year, $13 million grant will help scientists and clinicians at Fred Hutchinson Cancer Research Center try to improve outcomes for these patients. Created by the new grant, the Hutch’s new Specialized Program of Research Excellence in Lung Cancer will bring together experts from across Fred Hutch and its partner organizations to fast-track the latest breakthroughs in its labs to patients and those at risk of developing the disease. 

Paul Lampe, Research Professor, Global Health, is mentioned in this story.

Read the entire article at Fred Hutch.